He graduated from Dokuz Eylul University Faculty of Medicine in 1996 with a second degree. In 1997, he started to work as an assistant at Ege University Internal Diseases Clinic. He became an internal medicine specialist in 2002 and started his hematology sub-branch training in the Hematology clinic of the same faculty and became a hematology specialist in 2005. Between October 2005 and September 2006, he did his military service in Ankara Gülhane Military Medical Academy Hematology clinic. He became Associate Professor of Hematology in 2010 and Professor in 2018. Fahri Şahin Turkish Hematology Association, Hematology Specialization Association, Aegean Hemophilia Association, Aydın Hemophilia Association, Clinical Research Association, Aegean Hematology Oncology Association, Aegean Adult Hemophilia Association, The European Association for Haemophilia and Allied Disorders (EAHAD), International PNH Interest Group (IPIG) ) is a member. He is one of the founding members of the Aegean Adult Hemophilia Association and Aegean Hematology Oncology Association, and he is currently the general secretary of the Aegean Hematology Oncology Association and the president of the Aegean Adult Hemophilia Association. In 2010, he was elected as an honorary member by the Aegean Science and Technology Community (EBILTET) board of directors. Dr. Fahri Şahin, who was elected as the chairman of the "Molecular Hematology and Cytogenetics Scientific Subcommittee" of the Turkish Society of Hematology in 2010, organized successful courses and training meetings during his four-year tenure.
Turkish Society of Hematology "Young Researcher" award in 2002, 2003 and 2004, "Proceeding Awards" in National Hematology Congresses in 2004, 2007 and 2008, Turkish Clinical Biochemistry Association in 2009, IX. He received the "Best Oral Presentation Award" at the National Clinical Biochemistry Congress, and the "Hemapheresis Society Science Encouragement Award" at the 4th National Hemapheresis Congress in the same year. It received the TÜRKBA award for its multicenter CML study, which was conducted for the first time in our country and included 1133 patients, within the scope of the studies of the Turkish Blood Science Network (TÜRKBA) initiated for the first time by the Turkish Hematology Association in 2012.
He has 129 articles published in national and international journals. A total of 460 papers were published, 200 of which were in international congresses. He has authored a total of 18 book chapters, five of which are international.
He has worked as both an executive and assistant researcher in over 70 national and international preclinical-clinical studies.
In 2013, he established the Adult Hemophilia polyclinic within the body of Ege University Faculty of Medicine, Department of Internal Diseases. This polyclinic is the first adult Hemophilia Polyclinic in our country and set an example for other centers. The adult hemophilia polyclinic, named Aegean Adult Hemophilia and Thrombosis Center in 2014, became recognized by EUHASS (European Haemophilia Safety and Surveillance) on the map of European Hemophilia Centers and was accredited in 2018.
Again, by establishing the first and only adult hemophilia school (Ege Adult Hemophilia School-EHHO, www.ehho.org) in the field of hemophilia, it has undertaken the task of raising awareness and informing patients and their relatives. Dr. Fahri Şahin, who sees the need in the field of rare diseases, established a multidisciplinary organization especially related to Paroxysmal Nocturnal Hemoglobinuria (PNH) disease in 2014 and brought it to the international platform. (PNH Education and Study Group, PESG) (www.pesg.org).
He is both on the organizing committee and the general secretariat of Aegean Hematology Oncology Congress, which has national participation every year, and Aegean Hematology Oncology Symposium (AHOS), which is an international symposium, and co-chairman of the Educational Symposium on Hemophilia Cases (HEVES) with national participation.
His work in the field of Hematology is in the fields of Anemias, Thrombocytopenias (ITP), Multiple Myeloma and Plasma Cell Diseases, Lymphomas, Acute and Chronic Leukemias, Myelodysplastic Syndromes (MDS), Myeloproliferative diseases (Polycytemia vera, Essential thrombocythemia and Myelofibrosis), Hemophilia, PNH and Stem cell transplantation. continues.
Continuing his studies at Ege University Faculty of Medicine, Department of Internal Diseases, Department of Hematology, Dr. Fahri Şahin has also been serving as the Deputy Chief Physician of Ege University Hospital since 02 October 2020.
